Hubert Chen
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
Hubert Chen is Chief Medical Officer at Attovia Therapeutics, Inc. since 2024.
Former positions include Medical Director at Genentech, Inc. and Senior Vice President-Clinical Development at Krystal Biotech, Inc. Education includes graduate studies at Harvard University and a doctorate from Stanford University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/08/2026 | 2.960 ( 0,01 % ) | 0 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/03/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 01/03/2024 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.